Compare GBIO & PXLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GBIO | PXLW |
|---|---|---|
| Founded | 2016 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.4M | 36.1M |
| IPO Year | 2020 | 2000 |
| Metric | GBIO | PXLW |
|---|---|---|
| Price | $5.11 | $6.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $10.67 | ★ $14.33 |
| AVG Volume (30 Days) | 75.9K | ★ 117.5K |
| Earning Date | 11-05-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $15,270,000.00 | ★ $33,205,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $23.74 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.00 | $4.67 |
| 52 Week High | $15.30 | $15.42 |
| Indicator | GBIO | PXLW |
|---|---|---|
| Relative Strength Index (RSI) | 40.76 | 46.61 |
| Support Level | $5.14 | $5.60 |
| Resistance Level | $5.38 | $7.09 |
| Average True Range (ATR) | 0.26 | 0.45 |
| MACD | 0.01 | 0.22 |
| Stochastic Oscillator | 18.36 | 64.69 |
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.